Hirva Mamdani
Physician · Barbara Ann Karmanos Cancer Institute - Detroit
Credentials: · · · · ·
History
2011–2014- 2005–2009
Doctor of Medicine
Research
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
Review · Frontiers in Immunology · 2022 · First of 5 authors · Corresponding · 295 citations
Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer
Molecular Cancer Therapeutics · 2021 · 184 citations
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
Journal of Clinical Oncology · 2022 · 117 citations
15 papers
10 papers
9 papers
8 papers
- MN
8 papers
7 papers
7 papers
6 papers
Clinical trials
- 2023–2030
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
Principal investigator · Recruiting · Phase 2
Hirva Mamdani
- 2022–2025
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Site PI · Unknown · Phase 1, Phase 2
Chipscreen Biosciences, Ltd.
- 2026–2029
First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy
Sub-investigator · Recruiting · Phase 1
Nerissa T. Viola